The "Health Care Provider Free Speech and Innovation Act" aims to protect licensed health care providers from disciplinary actions, professional sanctions, or civil and criminal liabilities when they communicate with patients, colleagues, or the public about emerging medical research, experimental treatments, innovative therapies, or off-label uses of medications. The bill stipulates that such communications must be made in good faith and not knowingly false or misleading. It also allows health care providers to recommend or utilize therapies that are not part of the current standard of care, provided that the provider believes it may benefit the patient, the patient gives informed consent, and the therapy is not expressly prohibited by law.

Additionally, the bill includes provisions that prevent retaliation from state licensing boards, employers, or insurers against health care providers exercising their rights under this chapter. It establishes a new chapter in the law, Chapter 332-O, which defines key terms such as "health care provider," "innovative therapy," and "good faith." The act also allows health care providers to bring civil actions for violations of this chapter, seeking various forms of relief, including compensatory and punitive damages. The bill does not compel insurers or employers to adopt non-standard treatments and emphasizes that any invalid provision will not affect the remainder of the chapter. The act is set to take effect 60 days after its passage.